Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2017 Filed Feb 6, 2017 17:23 UTC |
McCall Thomas DVice President and Gen'l Mgr.
|
Exercise / conversionCommon Stock | 679 | $0.00 | $0.00 |
DisclosureSEC source: 0001615186-17-000001 · edgardoc.xml · nonDerivative · entry 1 McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:21 UTC |
Lamb Scott EChief Financial Officer,
|
Exercise / conversionCommon Stock · Derivative | 914 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000001 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,828 Underlying: Common Stock · 914 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:21 UTC |
Lamb Scott EChief Financial Officer,
|
Tax withholdingCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000001 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,912 Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:21 UTC |
Lamb Scott EChief Financial Officer,
|
Exercise / conversionCommon Stock | 914 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000001 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock · Derivative | 3,758 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000001 · edgardoc.xml · derivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,518 Underlying: Common Stock · 3,758 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 1,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,816 Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 3,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-17-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| January 08, 2017 Filed Jan 9, 2017 18:01 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock · Derivative | 362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-002878 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 362 shares Expires 2017-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| January 08, 2017 Filed Jan 9, 2017 18:01 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock | 362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-002878 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| December 07, 2016 Filed Dec 7, 2016 23:05 UTC |
McGrody Kevin JController
|
Exercise / conversionCommon Stock · Derivative | 222 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001615192-16-000012 · edgardoc.xml · derivative · entry 3 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445 Underlying: Common Stock · 222 shares Expires 2018-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| December 07, 2016 Filed Dec 7, 2016 23:05 UTC |
McGrody Kevin JController
|
Tax withholdingCommon Stock | 116 | $148.30 | $17,202.80 |
DisclosureSEC source: 0001615192-16-000012 · edgardoc.xml · nonDerivative · entry 2 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951 Read SEC document |
| December 07, 2016 Filed Dec 7, 2016 23:05 UTC |
McGrody Kevin JController
|
Exercise / conversionCommon Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0001615192-16-000012 · edgardoc.xml · nonDerivative · entry 1 McGrody Kevin J · CIK 0001615192 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2016 Filed Nov 14, 2016 23:53 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 325 | $143.67 | $46,691.26 |
DisclosureSEC source: 0001073398-16-000019 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,525 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.50 to $143.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 14, 2016 Filed Nov 14, 2016 23:53 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 1,700 | $142.73 | $242,645.25 |
DisclosureSEC source: 0001073398-16-000019 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,850 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.30 to $143.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 19:35 UTC |
SHERMAN RICHARD MDDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $38.85 Strike: $38.85 | $58,275.00 |
DisclosureSEC source: 0001073391-16-000010 · edgardoc.xml · derivative · entry 3 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-07-22 F2 · price: Transaction is the exercise of a derivative security; see Column 2. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 19:35 UTC |
SHERMAN RICHARD MDDirector
|
SaleCommon Stock | 1,500 | $140.60 | $210,900.00 |
DisclosureSEC source: 0001073391-16-000010 · edgardoc.xml · nonDerivative · entry 2 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,199 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 19, 2016. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 19:35 UTC |
SHERMAN RICHARD MDDirector
|
OtherCommon Stock | 1,500 | $38.85 | $58,275.00 |
DisclosureSEC source: 0001073391-16-000010 · edgardoc.xml · nonDerivative · entry 1 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,699 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $34.53 Strike: $34.53 | $51,795.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · derivative · entry 9 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-10-20 F3 · price: Transaction is the exercise of a derivative security; see Column 2. F2 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $27.45 Strike: $27.45 | $41,175.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · derivative · entry 8 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-07-21 F3 · price: Transaction is the exercise of a derivative security; see Column 2. F2 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $24.17 Strike: $24.17 | $36,255.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · derivative · entry 7 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2018-04-21 F3 · price: Transaction is the exercise of a derivative security; see Column 2. F2 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 1,500 | $140.60 | $210,900.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · nonDerivative · entry 6 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,348 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2015. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $34.53 | $51,795.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · nonDerivative · entry 5 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,848 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 1,500 | $140.60 | $210,900.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · nonDerivative · entry 4 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,348 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2015. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $27.45 | $41,175.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · nonDerivative · entry 3 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,848 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
SaleCommon Stock | 1,500 | $140.60 | $210,900.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · nonDerivative · entry 2 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,348 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2015. Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC |
SAUCEDO JOSEPH RDirector
|
OtherCommon Stock | 1,500 | $24.17 | $36,255.00 |
DisclosureSEC source: 0001190251-16-000017 · edgardoc.xml · nonDerivative · entry 1 SAUCEDO JOSEPH R · CIK 0001190251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,848 Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 21:22 UTC |
SHERMAN RICHARD MDDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $34.48 Strike: $34.48 | $51,720.00 |
DisclosureSEC source: 0001073391-16-000009 · edgardoc.xml · derivative · entry 6 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-04-20 F2 · price: Transaction is the exercise of a derivative security; see Column 2. Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 21:22 UTC |
SHERMAN RICHARD MDDirector
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $32.07 Strike: $32.07 | $48,105.00 |
DisclosureSEC source: 0001073391-16-000009 · edgardoc.xml · derivative · entry 5 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-02-04 F2 · price: Transaction is the exercise of a derivative security; see Column 2. Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 21:22 UTC |
SHERMAN RICHARD MDDirector
|
SaleCommon Stock | 1,500 | $123.00 | $184,500.00 |
DisclosureSEC source: 0001073391-16-000009 · edgardoc.xml · nonDerivative · entry 4 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,199 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 19, 2016. Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 21:22 UTC |
SHERMAN RICHARD MDDirector
|
SaleCommon Stock | 1,500 | $122.02 | $183,030.00 |
DisclosureSEC source: 0001073391-16-000009 · edgardoc.xml · nonDerivative · entry 3 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,699 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 19, 2016. Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 21:22 UTC |
SHERMAN RICHARD MDDirector
|
OtherCommon Stock | 1,500 | $34.48 | $51,720.00 |
DisclosureSEC source: 0001073391-16-000009 · edgardoc.xml · nonDerivative · entry 2 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,199 Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 21:22 UTC |
SHERMAN RICHARD MDDirector
|
OtherCommon Stock | 1,500 | $32.07 | $48,105.00 |
DisclosureSEC source: 0001073391-16-000009 · edgardoc.xml · nonDerivative · entry 1 SHERMAN RICHARD MD · CIK 0001073391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,699 Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 324 | $43.62 Strike: $43.62 | $14,132.88 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · derivative · entry 7 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 324 shares Expires 2021-07-20 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC |
Lamb Scott EChief Financial Officer,
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,150 | $43.12 Strike: $43.12 | $49,588.00 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · derivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,150 shares Expires 2021-02-02 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 700 | $121.93 | $85,353.03 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.91 to $121.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 450 | $120.82 | $54,370.49 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.80 to $120.83, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 1,150 | $43.12 | $49,588.00 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,531 Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC |
Lamb Scott EChief Financial Officer,
|
SaleCommon Stock | 324 | $122.01 | $39,531.01 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.75 to $122.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC |
Lamb Scott EChief Financial Officer,
|
OtherCommon Stock | 324 | $43.62 | $14,132.88 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,705 Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,677 | $58.79 Strike: $58.79 | $98,590.83 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 21 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 1,677 shares Expires 2024-02-24 F15 · price: Transaction is the exercise of a derivative security; see Column 2. F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 800 | $58.79 Strike: $58.79 | $47,032.00 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 20 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,177 Underlying: Common Stock · 800 shares Expires 2024-02-24 F15 · price: Transaction is the exercise of a derivative security; see Column 2. F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 1,677 | $121.35 | $203,500.09 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 16 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.87 to $122.19, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherCommon Stock | 1,677 | $58.79 | $98,590.83 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 15 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,677 Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 800 | $121.89 | $97,512.00 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 14 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.75 to $122.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherCommon Stock | 800 | $58.79 | $47,032.00 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 13 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 2,460 | $61.76 Strike: $61.76 | $151,929.60 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 22 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,446 Underlying: Common Stock · 2,460 shares Expires 2023-02-06 F15 · price: Transaction is the exercise of a derivative security; see Column 2. F16 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 11,957 | $58.79 Strike: $58.79 | $702,952.03 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 19 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,977 Underlying: Common Stock · 11,957 shares Expires 2024-02-24 F15 · price: Transaction is the exercise of a derivative security; see Column 2. F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 12,833 | $58.79 Strike: $58.79 | $754,452.07 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 18 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,934 Underlying: Common Stock · 12,833 shares Expires 2024-02-24 F15 · price: Transaction is the exercise of a derivative security; see Column 2. F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 13,634 | $58.79 Strike: $58.79 | $801,542.86 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 17 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,767 Underlying: Common Stock · 13,634 shares Expires 2024-02-24 F15 · price: Transaction is the exercise of a derivative security; see Column 2. F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:30 UTC |
RIGGS STEVENVP Operations
|
SaleCommon Stock | 2,700 | $122.07 | $329,577.93 |
DisclosureSEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 12 RIGGS STEVEN · CIK 0001189724 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.99 to $122.18, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.